Advanced search
Publication Cover
Amyotrophic Lateral Sclerosis Volume 11, 2010 - Issue 3
Journal homepage
507
Views
64
CrossRef citations to date
0
Altmetric
REVIEW ARTICLE

Toward more efficient clinical trials for amyotrophic lateral sclerosis

Merit E. Cudkowicz Massachusetts General Hospital, Boston, MassachusettsCorrespondence[email protected]
,
Jon Katz California Pacific Medical Center, San Francisco, California
,
Dan H. Moore California Pacific Medical Center, San Francisco, California
,
Gilmore O’neill BiogenIdec, Cambridge, Massachusetts
,
Jonathan D. Glass Emory University, Atlanta, Georgia
,
Hiroshi Mitsumoto Columbia University, New York City, New York
,
Stanley Appel Methodist Hospital, Houston, Texas
,
Bernard Ravina University of Rochester, Rochester, New York
,
Karl Kieburtz University of Rochester, Rochester, New York
,
Ira Shoulson University of Rochester, Rochester, New York
,
Petra Kaufmann Columbia University, New York City, New York
,
Jaffar Khan Emory University, Atlanta, Georgia
,
Ericka Simpson Methodist Hospital, Houston, Texas
,
Jeremy Shefner SUNY at Upstate, Syracuse, New York
,
Bruce Levin Columbia University, New York City, New York
,
Valerie Cwik Muscular Dystrophy Association, Tucson, Arizona, USA
,
David Schoenfeld Massachusetts General Hospital, Boston, Massachusetts
,
Swati Aggarwal Massachusetts General Hospital, Boston, Massachusetts
,
Michael P. McDermott University of Rochester, Rochester, New York
&
Robert G. Miller California Pacific Medical Center, San Francisco, California
 show all
Pages 259-265 | Received 03 Jul 2009, Accepted 21 Sep 2009, Published online: 04 Dec 2009

References

  • Ravina B, Fagan S, Hart R, Hovinga C, Murphy D, Dawson T, . Neuroprotective agents for clinical trials in Parkinson’s disease: a systematic assessment. Neurology. 2003; 60:1234–9.
  • Frank R, Hargreaves R . Clinical biomarkers in drug discovery and development. Nature. 2003; 2:566–80.
  • Welch E, Barton E, Zhuo J, Tomizawa Y, Friesen W, Trifillis P, . PTC124 targets genetic disorders caused by nonsense mutations. Nature. 2007; 447:87–93.
  • Maeda J, Ji B, Irie T, Tomiyama T, Maruyama M, Okauchi T, . Longitudinal, quantitative assessment of amyloid, neuroinflammation, and anti-amyloid treatment in a living mouse model of Alzheimer’s disease enabled by positron emission tomography. Neurobiol Dis. 2007;27:10957–68.
  • Mathisa C, Loprestia B, Klunk W . Impact of amyloid imaging on drug development in Alzheimer’s disease. Nuclear Medicine and Biology. 2007;34:809–22.
  • Cudkowicz M, Shefner J, Simpson E, Grasso D, Yu H, Zhang H . Arimoclomol at dosages up to 300 mg/day is well tolerated and safe in ALS. Muscle and Nerve. 2008; 38:837–44.
  • Herson J . Predictive probability early termination plans for phase II clinical trials. Biometrics. 1979; 5:775–83.
  • The NINDS NET-PD Investigators. A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson’s disease. Neurology. 2006; 66:664–71.
  • The NINDS NET PD Investigators. A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson’s disease. Neurology. 2007; 68:20–8.
  • Gordon P, Cheung Y, Levin B, Andrews H, Doorish C, Macarthur R, . A novel, efficient, randomized selection trial comparing combinations of drug therapy for ALS. Amyotroph Lateral Scler. 2008;9:212–22.
  • Levy G, Kaufmann P, Buchsbaum R, Montes J, Barsdorf A, Arbing R, . A two-stage design for a phase II clinical trial of coenzyme Q10 in ALS. Neurology. 2006;66:660–3.
  • Schoenfeld DA, Cudkowicz M . Design of phase II ALS clinical trials. Amyotroph Lateral Scler. 2008;9:16–23.
  • Whitehead J . The Design and Analysis of Sequential Clinical Trials. 2nd. New York:John Wiley and Sons; 1997.
  • Gordon PH, Moore DH, Miller RG, Florence JM, Verheijde JL, Doorish C, . Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomized trial. Lancet Neurology. 2007;6:1045–53.
  • Miller R, Bradley W, Cudkowicz M, Hubble J, Meininger V, Mitsumoto H, . Phase II/III randomized trial of TCH346 in patients with ALS. Neurology. 2007;69:776–84.
  • Spiegelhalter D, Abrams K, Myles J . Bayesian Approaches to Clinical Trials and Health-Care Evaluation. New York: Wiley; 2004.
  • Fornai F, Longone P, Cafaro L, Kastsiuchenka O, Ferrucci M, Manca M, . Lithium delays progression of amyotrophic lateral sclerosis. PNAS. 2008;105:2052–7.
  • Qureshi M, Schoenfeld D, Paliwal Y, Shui A, Cudkowicz M . The natural history of ALS is changing: improved survival. Amyotroph Lateral Scler. 2009; in press.
  • Cudkowicz M, Shefner J, Schoenfeld D, Zhang H, Andreasson K, Rothstein J, . Trial of celecoxib in amyotrophic lateral sclerosis. Annals of Neurology. 2006;60:22–31.
  • Shefner JM, Cudkowicz ME, Schoenfeld D, Conrad T, Taft J, Chilton M, . NEALS. A clinical trial of creatine in amyotrophic lateral sclerosis. Neurology. 2004;63:1656–61.
  • Sorenson E, Windbank A, Mandrekar J, Bamlet W, Appel S, Armon C, . Subcutaneous IGF-1 is not beneficial in two-year ALS trial. Neurology. 2008;71:1770–5.
  • Pocock S, . Clinical Trials: a Practical Approach. Chichester: John Wiley and Sons; 1983.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.